In NSCLC, circCPA4 upregulates intracellular and extracellular exosomal PD‐L1 levels by sponging miRNA let‐7, inactivating CD8+ T cells, promoting cell stemness, enhancing EMT, and increasing resistance to cisplatin.351. Here, CD8A is linked to non-small cell lung carcinoma.